Health & Nutrition

Themenbereich / / Health & Nutrition


Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

Clinical Nutrition Industry SWOT Analysis, Competitive Strategies, and Growth Opportunities, 2025

Global clinical nutrition market is anticipated to witness an exponential growth in the forecast period. Clinical nutrition implies the correlation between human bodies and nutrients. Clinical nutrition is proportional to the treatment and diagnosis of diseases that affect the absorption, intake, and metabolism of dietary elements. It also stimulates health through prevention of diet-related diseases. The factors that propel the growth of the market include growing aged population, escalating birth rate and premature births, rise in diabetes and metabolic disorders, changing dietary habits an ...

10.02.2020

Glucosamine Market Key Players, Industry Threads, and Competitive Analysis

The Global Glucosamine Market is estimated to develop at a substantial CAGR for the duration of the prediction. Increasing possibility of the application of the product in the production of nutritious enhancements that help in the deterrence of osteoarthritis between the customers likely to trigger the demand above the following years. Growing sum of vegan customers mainly in technologically advanced nations comprising the U.S.A is projected to be additional motivator for the business above the prediction period. The product is mass-produced from shellfish comprising crab and shrimp; yet, the ...

27.08.2019

Clinical Nutrition Industry Emerging Trends, Revenue Analysis, and Global Demand

Global clinical nutrition market is anticipated to witness an exponential growth in the forecast period. Clinical nutrition implies the correlation between human bodies and nutrients. Clinical nutrition is proportional to the treatment and diagnosis of diseases that affect the absorption, intake, and metabolism of dietary elements. It also stimulates health through prevention of diet-related diseases. The factors that propel the growth of the market include growing aged population, escalating birth rate and premature births, rise in diabetes and metabolic disorders, changing dietary habits an ...

05.07.2019

Weight Loss Supplement Market Key Players Analysis and Competitive Strategies

Global weight loss supplement market is anticipated to grow significantly in the forecast period owing to the explosive demand for weight loss dietary supplements. Weight loss dietary supplement is the diet taken in place of healthy foods. They comprise herbs, minerals, and fibers in different quantity and various combinations. However, weight loss supplements are highly preferred by consumers worldwide and are not be ideal for health conditions like heart disease, liver disorder, diabetes, blood pressure, etc. The market is driven by factors like consumerst. Nevertheless, rising incidence of ...

05.07.2019

Facial Aesthetics Market Application, Trends, and End User Analysis Report

Global facial aesthetics market is anticipated to witness an exponential growth in the forecast period. Facial aesthetics help in removing wrinkles and improving the aesthetic appeal of the face. Facial aesthetic products are applied on the lips or skin to plump up the tissues and repair the collagen lost due to aging. The factors that propel the growth of the market include growing cosmetic treatment among customers, shifting preference of customers towards minimally invasive and non-invasive procedures, growing population aged 60, increasing facial aesthetic procedures comprising smaller in ...

24.06.2019

Feminine Probiotic Supplement Market

Global feminine probiotic supplement market is expected to grow at a significant CAGR of 7.22% in the upcoming period as the scope and its applications are rising enormously across the globe. Probiotics are termed as bacterial cultures or live microorganisms that able to withstand the gastrointestinal tracts condition and survive to act beneficial the host by balancing the gastrointestinal microbiota. The main purpose of probiotics is to reinstate the vaginal lactobacilli microflora. The factors that are playing a major role in the growth of the market are growing occurrence of digestive diso ...

24.06.2019

Protein Expression Market – Size, Share, Trends| Global Forecast

The protein expression market is segmented on the basis of systems type, product, application and end user. Protein expression is a technique or methodology in which proteins are characterized, modified, and synthesized in the host cells. The selected protein is typically achieved by the modification or alteration of the protein expression process in a living cell. Various kinds of protein expression systems are used to produce a broad range of therapeutic proteins such as insulin, interferons, and interleukins. Protein Expression Market Based on Product; On the basis of product, the market ...

02.05.2019

Dietary fibers market to hit USD 11.83 billion by 2025

21 November 2018, the global Dietary Fibers Market size is expected to reach USD 11.83 billion in 2025. Rising popularity of fiber-fortified foods as a result of increasing awareness about maintaining proper gut health is expected to be a favorable factor for the market. Furthermore, rising prevalence of lifestyle diseases owing to hectic working schedule is expected to shift inclination of consumers toward nutraceuticals including functional foods. This factor is anticipated to further propel market growth. Government support and rising funding aimed at promoting organic farming in key marke ...

21.11.2018

Sucralose Market Analysis, Price Trends and Growth Report, 2015 to 2025

16 November 2018, the global Sucralose Market size is expected to reach USD 883.9 million by 2025. It is anticipated to expand at a CAGR of 3.0% during the forecast period. The product finds use as a tabletop sweetener during the formulation of food products including, juices, carbonated drinks, dairy products, sugar-free chewing gums, confectionery, and bakery goods. The demand for sucralose is expected to grow over the forecast period on account of its positioning as an effective alternative to sugar. Sucralose is sweeter than sugar and is a cheaper substitute which does not cause dental cav ...

16.11.2018

EUROPE AND USA: AGREEMENT ON DEFINITION AND DIAGNOSIS OF SPECIFIC FORM OF HIGH BLOOD PRESSURE

Physician from Karl Landsteiner University of Health Sciences plays a part in global consensus-building process Krems (Austria), 6 November 2018 President of the European body. Medical experts have agreed on the definition and diagnosis of a condition known as supine hypertension. This refers to high blood pressure that occurs when the sufferer is in a recumbent position. This is often caused by neurodegenerative conditions such as Parkinsonition is essential. But until recently, no international standard was in place. SIGNIFICANT PRESSURE TO REACH AGREEMENT Speaking about this joint suc ...

06.11.2018

Omega 7 Palmitoleic Acid (POA) Market Size, Growth and Trend Analysis, 2015 to 2025

31 October 2018, the global Omega 7 Palmitoleic Acid (POA) Market size is expected to reach 54.9 kilo tons by 2025. The product is projected to witness rise in nutraceutical applications on account of exception properties that improve cardiovascular health, insulin sensitivity, and reduce inflammation in human body. The dry eye condition segment is projected to register the fastest growth among applications. It is anticipated to expand at a revenue CAGR of 14.9% from 2017 to 2025. Omega 7 POA is capable of relieving the occasional dry eyes caused by exposure to sunlight, wind, contact lenses, ...

31.10.2018

How You Can Use Marijuana101 In Positive Manner?

United States (23-10-2018) I have lots of questions about medication testing and also how to maneuver a very simple pee drug evaluation. A lot of people want to know more about natural home treatments and organic methods to go this drug evaluation. Regrettably I am unable to suggest any natural home treatments for medication evaluation only because almost all of these will not do the job, and also many who have high success speed continue to be really unreliable. Odds are extremely high for you to employ homemade remedies like Certo, Niacin or even Palo Azul tea to wash your own body. Natural ...

23.10.2018

Fructo Oligosaccharides (FOS) Market Size, Application Analysis and Forecast, 2013 to 2024

17 October 2018, the global Fructo Oligosaccharides (FOS) Market size is expected to reach USD 3.52 billion by 2024. This prebiotic is gaining popularity as a functional ingredient in food and beverage on account of rising consumer awareness about fiber-fortified goods. FOS helps maintain growth of nonpathogenic intestinal micro flora. Rising demand for infant foods from emerging economies including, China and India is projected to be a significant trend. Furthermore, expansion of functional food industry and new product launches by Arla Foods, Danone, and such other companies is expected to s ...

17.10.2018

Bio-Leinöl in Vegicaps – Hoher Gesundheitsnutzen der rein pflanzlichen Omega-3-Fettsäure ALA

Vor einigen Jahrzehnten haben Gesundheitsforscher aus den westlichen Industrienationen verwundert festgestellt, dass es V Die Alpha-Linolens den direkten Verzehr nicht gerade zu einem kulinarischen Vergnn es bezogen werden. Quelle: Zhang et al. PLoS One 2013 Jul 5;8(7):e68489 Navitum Pharma GmbH Tel: 0611-18843740 FAX: 0611-18843741 ...

22.08.2018

IntelGenx Submits Montelukast VersaFilm(TM) Clinical Trial Application With Health Canada

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/09/17 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx"), today announced that it has submitted a clinical trial application ("CTA") to Health Canada for approval to initiate its Phase 2a proof of concept ("POC") study with Montelukast in mild to moderate Alzheimer''s Disease ("AD").The study, entitled "A randomized Phase IIa, multi-center, double-blind, placebo-controlled study to assess the safety, feasibility, tolerability, and efficacy of a new bucc ...

09.11.2017

IntelGenx Reports Third Quarter 2017 Financial Results

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/09/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter ended September 30, 2017. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise.2017 Third Quarter Financial Highlights:Recent Developments:"With the completion of convertible debenture offering during the third quarter, we secured the necessary fi ...

09.11.2017

Nephros Reports Third Quarter 2017 Financial Results

RIVER EDGE, NJ -- (Marketwired) -- 11/09/17 -- Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), today announced financial results for the three months ended September 30, 2017."Our 93% year-over-year revenue growth in the third quarter suggests that our focus on an expanded product portfolio and strategic dist ...

09.11.2017

Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits

RIVER EDGE, NJ -- (Marketwired) -- 11/06/17 -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), announced today the receipt of $1.9 million in tax credit certificates from New Jersey Economic Development Authority (NJEDA), which are expected be sold later this quarter for over $1.75 million in net proceeds.Nephros received the tax credit ce ...

06.11.2017

IntelGenx to Report Third Quarter 2017 Financial Results on November 9, 2017 - Conference Call to Follow

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/02/17 -- IntelGenx Technologies Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it will release its third quarter 2017 financial results after market close on November 9, 2017.An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:Webcast Registration:Following the live call, a replay will be available o ...

02.11.2017

Tauriga Sciences, Inc. Confirms Canadian Trading Halt Lifted at Open of Market on November 1, 2017

NEW YORK, NY -- (Marketwired) -- 11/01/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), a company engaged in building businesses in the life sciences space, today announced that the Autorité des Marchés Financiers (the "AMF") provided the Company written notification on October 31, 2017 that the AMF has lifted the Canadian Cease Trade Order ("Trading Halt"). Trading in the Company''s securities for its Canadian-based shareholders will commence at market open Wednesday, November 1, 2017.The Trading Halt was initially ...

01.11.2017


Page 1 from 94:  1 2  3  4  5  .. » 94





All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 64


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.